Analyzing treatment at the point of care
Predicting oncology utilization patterns
PrecisionIQ helps you forecast the adoption of new products and evaluate market dynamics for business development opportunities. Our projection methodology uses real-world longitudinal oncology treatment data across over 80 malignancies to account for physician behavior—such as under-dosing, toxicity management and drug cycle utilization.
We apply parameters such as age, gender, disease stage, biomarkers and line of therapy to uncover insights into the current patterns of national drug usage. Using more refined population segmentation and statistical estimation, we can project adoption and utilization within an individual condition across and within subpopulations.
Insight into patterns of care
Our IntelliVIEW solution offers a real-time snapshot of clinical usage patterns and trends at the drug, regimen or patient level. It provides you with nationally projected drug utilization for both IV and oral oncolytics, as well as a longitudinal track of all lines of therapy from over 69,000 unique cancer patients per year.
Broken out across four regions of the United States, you can gain powerful insights from metrics segmented by specific drug and regimen, patient characteristics and unique patient condition. With such a robust data set at your disposal, you can more effectively understand your market share and analyze patient populations to evaluate patterns in dosing.